24 Recruiting Studies at University Of Arizona Cancer Center
Active clinical trials at this research center, sourced directly from the NIH registry.
π Tucson, Arizona
All research centersRecruiting Studies at University Of Arizona Cancer Center
π΅ Active, Not Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
Unresectable or Metastatic Melanoma or Advanced Solid Tumors
View Study & Checklist β π΅ Active, Not Recruiting Observational / Diagnostic π§ Behavioral & Psychological Program
Hispanic Adapted and Culturally Relevant Exercising Together
Neoplasms
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRΞ±) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
High Grade Ovarian Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
Breast Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
Pancreatic Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Intravesical Gem/Doce in Patients With NMIBC
Urinary Bladder Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
Hepatocellular Carcinoma
View Study & Checklist β π΅ Active, Not Recruiting Phase3 π Investigational Drug / Biologic
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
Melanoma
View Study & Checklist β π‘ Not Yet Recruiting Phase3 π Investigational Drug / Biologic
A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
View Study & Checklist β π‘ Not Yet Recruiting Early Phase1 π Investigational Drug / Biologic
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Pancreatic Cancer
View Study & Checklist β π’ Recruiting Observational / Diagnostic π Clinical Research Protocol
SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants
Other Skin Changes Due to Chronic Exposure to Nonionizing Radiation
View Study & Checklist β π’ Recruiting Observational / Diagnostic π§ Behavioral & Psychological Program
Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
Cancer Metastatic
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Colorectal Neoplasms
View Study & Checklist β π’ Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Advanced Solid Tumor
View Study & Checklist β π’ Recruiting Observational / Diagnostic π§ Behavioral & Psychological Program
A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
Cancer
View Study & Checklist β π’ Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Breast Cancer
View Study & Checklist β π’ Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
Solid Tumor Malignancies
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
A Study of HC-7366 in Combination With Belzutifan (WELIREGβ’) in Patients With Renal Cell Carcinoma
Renal Cell Carcinoma
View Study & Checklist β π’ Recruiting Phase3 π Investigational Drug / Biologic
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma (FL)
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Advanced Solid Tumors
View Study & Checklist β π’ Recruiting Observational / Diagnostic π§ Behavioral & Psychological Program
The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
Lung Cancer - Non Small Cell
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
HER2/Neu+ Uterine Serous Carcinoma
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
Advanced Solid Tumor
View Study & Checklist β